Hevolution logo

Hevolution

Asia, Ar Riyad, Saudi Arabia, Riyadh

Description

Hevolution is a biotechnology research company that provides age-related therapeutics.

Investor Profile

Hevolution has made 5 investments, with 3 in the past 12 months and 60% as lead.

Stage Focus

  • Series A (60%)
  • Grant (20%)
  • Series B (20%)

Country Focus

  • United States (80%)
  • Switzerland (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Life Science
  • Non Profit
  • Manufacturing
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hevolution frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 1
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 1
Italian Angels for Growth
Europe, Lombardia, Italy, Milan
Co-Investments: 1
Evotec
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
Apollo Health Ventures
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
b2venture
Europe, Berlin, Germany, Berlin
Co-Investments: 1
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1
Ahren Innovation Capital
Europe, England, United Kingdom, London
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Hevolution?

Tune Therapeutics

Durham, North Carolina, United States

Tune Therapeutics is an epigenetic programming platform for the treatment of disease.

BiotechnologyHealth CareTherapeutics
Series BJan 12, 2025
Amount Raised: $175,000,000
Vandria

Lausanne, Vaud, Switzerland

Vandria creates mitophagy inducers that renew cells to address ageing and chronic disorders.

ManufacturingPharmaceutical
Series AAug 21, 2024
Amount Raised: $10,100,000
Rubedo Life Sciences

Sunnyvale, California, United States

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

BiotechnologyHealth CareLife Science
Series AApr 22, 2024
Amount Raised: $40,000,000
Aeovian Pharmaceuticals

San Francisco, California, United States

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AMar 28, 2024
Amount Raised: $50,000,000
Impetus Grants

San Francisco, California, United States

Impetus Grants provide funds for scientists to immediately begin working on the most important topics in aging biology.

Non Profit
GrantJul 24, 2023
Amount Raised: $10,000,000